Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms ; volume:19 ; number:6 ; day:22 ; month:8 ; year:2017 ; pages:1537-1549 ; date:11.2017
The AAPS journal / American Association of Pharmaceutical Scientists ; 19, Heft 6 (22.8.2017), 1537-1549, 11.2017
- Keyword
-
Arzneimittelentwicklung
Arzneimitteldesign
- Creator
-
Hermans, Andre
- Contributor
-
Abend, Andreas M.
Kesisoglou, Filippos
Flanagan, Talia
Cohen, Michael J.
Diaz, Dorys A.
Mao, Y.
Zhang, Limin
Webster, Gregory K.
Lin, Yiqing
Hahn, David A.
Coutant, Carrie A.
Grady, Haiyan
SpringerLink (Online service)
- DOI
-
10.1208/s12248-017-0117-1
- URN
-
urn:nbn:de:1111-201801086492
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hermans, Andre
- Abend, Andreas M.
- Kesisoglou, Filippos
- Flanagan, Talia
- Cohen, Michael J.
- Diaz, Dorys A.
- Mao, Y.
- Zhang, Limin
- Webster, Gregory K.
- Lin, Yiqing
- Hahn, David A.
- Coutant, Carrie A.
- Grady, Haiyan
- SpringerLink (Online service)
Other Objects (12)
Biorelevant dissolution test methods for modified release dosage forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. Case example: Naproxen
In vivo-relevant mini-scale biphasic dissolution model for the development of solid oral dosage forms
The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
Combined assessment of dissolution and epithelial permeability of solid oral dosage forms
Distributive laws for monotone specifications
Executable specifications for language implementation
Biopredictive disintegration and dissolution of solid oral dosage forms : biorelevant in vitro tests for enteric-coated dosage forms and development of fast dissolving pH-responsive polymers
Biorelevant dissolution test methods for modified release dosage forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. Case example: Naproxen
In vivo-relevant mini-scale biphasic dissolution model for the development of solid oral dosage forms
The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
Combined assessment of dissolution and epithelial permeability of solid oral dosage forms
Distributive laws for monotone specifications
Executable specifications for language implementation
Biopredictive disintegration and dissolution of solid oral dosage forms : biorelevant in vitro tests for enteric-coated dosage forms and development of fast dissolving pH-responsive polymers
Biorelevant dissolution test methods for modified release dosage forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. Case example: Naproxen
In vivo-relevant mini-scale biphasic dissolution model for the development of solid oral dosage forms
The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
Combined assessment of dissolution and epithelial permeability of solid oral dosage forms
Distributive laws for monotone specifications
Executable specifications for language implementation